BioLASCO Taiwan Co., Ltd. (TPEX:6662)
Taiwan · Delayed Price · Currency is TWD 29.90
-0.50 (-1.64%)
Apr 20, 2026, 1:09 PM CST
BioLASCO Taiwan Market Cap
BioLASCO Taiwan has a market cap or net worth of 765.8 million as of April 20, 2026. Its market cap has decreased by -16.71% in one year.
Market Cap
765.80M
Enterprise Value
710.88M
Revenue
262.66M
Ranking
n/a
PE Ratio
18.12
Stock Price
29.90
Market Cap Chart
Since January 4, 2018, BioLASCO Taiwan's market cap has decreased from 1.58B to 765.80M, a decrease of -51.56%. That is a compound annual growth rate of -8.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 778.60M | -1.94% |
| Dec 31, 2025 | 793.97M | -6.34% |
| Dec 31, 2024 | 847.76M | -0.30% |
| Dec 29, 2023 | 850.32M | 11.22% |
| Dec 30, 2022 | 764.52M | -1.97% |
| Dec 30, 2021 | 779.89M | -13.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Holy Stone Healthcare | 1.24B |
| Lukas Biomedical | 1.13B |
| Taiwan Advance Bio-Pharmaceutical | 1.13B |
| GeneReach Biotechnology | 1.12B |
| Level Biotechnology | 1.09B |
| TCI GENE | 967.06M |
| NatureWise Biotech & Medicals | 897.75M |
| Neith | 749.77M |